Browsing by Subject CDK 4/6 inhibitors
Showing results 1 to 1 of 1
Issue Date | Title | Author(s) |
---|---|---|
2021 | Abemaciclib, a third CDK 4/6 inhibitor for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced or metastatic breast cancer | El Hachem, Georges; Gombos, Andrea; Awada, Ahmad |